Extracorporeal photopheresis: how, when, and why.

@article{Ward2011ExtracorporealPH,
  title={Extracorporeal photopheresis: how, when, and why.},
  author={David M Ward},
  journal={Journal of clinical apheresis},
  year={2011},
  volume={26 5},
  pages={276-85}
}
Extracorporeal photopheresis (ECP) is a well-tolerated procedure that suppresses T-lymphocyte activity in a clonally-specific way. It is an effective therapy that has established indications in the management of cutaneous T-cell lymphoma, graft-versus-host disease and some scenarios of solid-organ transplant rejection. It is being used increasingly around the world. Its applications are evolving, including exploration of its potential for treating autoimmune diseases where cytotoxic T-cell… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 65 references

Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease

  • M Fimiani, M Di Renzo, P. Rubegni
  • Br J Dermatol
  • 2004
Highly Influential
8 Excerpts

Crohn’s Disease Photopheresis Study Group. Extracorporeal photopheresis for the treatment of refractory Crohn’s disease: results of an open-label pilot study

  • MT Abreu, C von Tirpitz, +14 authors W Reinisch
  • Inflamm Bowel Dis 2009;15:829–836
  • 2009
2 Excerpts

Similar Papers

Loading similar papers…